Dopaminergic receptors: A new antihypertensive mechanism


Abstract:

The neurotransmitter dopamine, precursor of noradrenaline, induces a variety of cardiovascular and renal physiological responses, including an increase in myocardial contractility and cardiac output without changes in heart rate, passive and active vasodilatation, diuresis and natriuresis. These responses result from its interaction with the dopamine receptors D<inf>1</inf>, D<inf>2</inf>, D<inf>3</inf>, D<inf>4</inf> and D<inf>5</inf>. In addition, recent findings suggest the existence of D<inf>6</inf> and D<inf>7</inf> receptors. In some types of hypertension dopamine is known to influence the control of arterial pressure by influencing the central and peripheral nervous system and target organs such as the kidneys and adrenal glands. Since dopamine and its derivatives have been shown to have antihypertensive effects, it is important to review the physiological and pharmacological aspects of dopamine and its receptors, and the clinical uses that they could have in the therapy of arterial hypertension. © 2002 Lippincott Williams & Wilkins.

Año de publicación:

2002

Keywords:

  • dopamine
  • Dopamine agonist
  • dopamine receptor
  • Hypertension
  • Kidney

Fuente:

scopusscopus

Tipo de documento:

Other

Estado:

Acceso restringido

Áreas de conocimiento:

  • Hipertensión
  • Medicina interna
  • Medicina interna

Áreas temáticas de Dewey:

  • Farmacología y terapéutica
  • Enfermedades
  • Fisiología humana
Procesado con IAProcesado con IA

Objetivos de Desarrollo Sostenible:

  • ODS 3: Salud y bienestar
  • ODS 17: Alianzas para lograr los objetivos
  • ODS 2: Hambre cero
Procesado con IAProcesado con IA